Low-dose aspirin in the prevention of pre-eclampsia in China (APPEC study): protocol for a multicentre randomized controlled trial
DiscussionThis is the first and largest multicentre randomized controlled trial to assess the effect of LDA in preventing PE in a Chinese population. The results will potentially influence the prenatal care recommendations in China regarding intervention with LDA for PE.Trial registrationClinicalTrials.gov,NCT02797249. Registered on 7 June 2016.
Source: Trials - Category: Research Source Type: clinical trials
More News: Aspirin | China Health | Diabetes | Diabetes Type 1 | Eating Disorders & Weight Management | Endocrinology | Hospitals | Hypertension | Obesity | Perinatology & Neonatology | Pre-eclampsia | Pregnancy | Research | Study | Women